IFRX 6-K: Fda approval
InflaRx
Filed with the SEC on · accession 0001140361-26-042466
IFRX filed a 6-K (foreign company report) with the SEC on Nov 6, 2026. How foreign companies listed in the US report news and events — like an 8-K for them. The stock moved -7.7% by the first close after the filing.
Summary of the filing
InflaRx announced the peer-reviewed publication of positive first-in-human Phase 1 clinical data for izicopan (formerly INF904), an oral C5aR1 inhibitor, showing favorable safety and pharmacokinetic/pharmacodynamic profiles in 86 healthy participants.
Key details
How IFRX stock reacted
Close before
$1.35
Nov 5, 2026
First close after
-7.75%
$1.25
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for IFRX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for IFRX?
Click hereFrequently asked questions
What did IFRX file with the SEC on Nov 6, 2026?
IFRX filed a 6-K (Fda approval). InflaRx announced the peer-reviewed publication of positive first-in-human Phase 1 clinical data for izicopan (formerly INF904), an oral C5aR1 inhibitor, showing favorable safety and pharmacokinetic/pharmacodynamic profiles in 86 healthy participants.
What does a fda approval mean for IFRX stock?
For a small biotech one drug can be most of the company’s value. Approval opens sales; a rejection (complete response letter) can delay it by years.
How do I read a 6-K?
How foreign companies listed in the US report news and events — like an 8-K for them. Look at the exhibit names: "results", "resign", "notice" tell you the topic. Many 6-Ks are routine (meeting notices); results and leadership changes matter most.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 6-K (foreign company report): How foreign companies listed in the US report news and events — like an 8-K for them.
How did IFRX stock react to this filing?
IFRX closed at $1.35 before the filing and $1.25 on Nov 6, 2026 (-7.75%).
Other IFRX SEC filings
Get alerts when IFRX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days